EHS
EHS

Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol | BMC Gastroenterology


  • Schuppan D, Schattenberg JM. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol. 2013;28(Suppl 1):68–76.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Zhang H, Chen L, Xin Y, Lou Y, Liu Y, Xuan S. Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease: a meta-analysis. Hepatmon. 2014;14(10):e23100.

    Article 

    Google Scholar
     

  • Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, et al. Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment. J Gastroenterol Hepatol. 2018;33(1):70–85.

    PubMed 
    Article 

    Google Scholar
     

  • National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. [Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update]. Zhonghua Gan Zang Bing Za Zhi. 2018;26(3):195–203. Chinese. https://doi.org/10.3760/cma.j.issn.1007-3418.2018.03.008.

  • Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589–600.

    PubMed 
    Article 

    Google Scholar
     

  • Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis. Metabolism. 2018;79:64–76.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Mantovani A, Byrne CD, Bonora E, Targher G. Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care. 2018;41(2):372–82.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Zheng X, Cao C, He Y, Wang X, Wu J, Hu H. Association between nonalcoholic fatty liver disease and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching. Lipids Health Dis. 2021;20(1):59.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Zhang M, Lin S, Wang MF, Huang JF, Liu SY, Wu SM, Zhang HY, Wu ZM, Liu WY, Zhang DC, et al. Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west? Bmc Gastroenterol. 2020;20(1):139.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263–73.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Jiang T, Chen X, Xia C, Liu H, Yan H, Wang G, Wu Z. Association between Helicobacter pylori infection and non-alcoholic fatty liver disease in North Chinese: a cross-sectional study. Sci Rep. 2019;9(1):4874.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • Mikolasevic I, Milic S, Turk WT, Grgic I, Jakopcic I, Stimac D, Wensveen F, Orlic L. Nonalcoholic fatty liver disease – A multisystem disease? World J Gastroenterol. 2016;22(43):9488–505.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Yang MH, Sung J, Gwak GY. The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population. J Clin Lipidol. 2016;10(2):289–98.

    PubMed 
    Article 

    Google Scholar
     

  • Sookoian S, Pirola CJ. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther. 2017;46(2):85–95.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Sporea I, Popescu A, Dumitrașcu D, Brisc C, Nedelcu L, Trifan A, Gheorghe L, Fierbințeanu BC. Nonalcoholic fatty liver disease: status quo. J Gastrointest Liver Dis. 2018;27(4):439–48.


    Google Scholar
     

  • Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82–97.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, Srishord M. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine. 2012;91(6):319–27.

    PubMed 
    Article 

    Google Scholar
     

  • Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862–73.

    PubMed 
    Article 

    Google Scholar
     

  • VanWagner LB, Armstrong MJ. Lean NAFLD: a not so benign condition? Hepatol Commun. 2018;2(1):5–8.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Hagström H, Nasr P, Ekstedt M, Hammar U, Stål P, Hultcrantz R, Kechagias S. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study. Hepatol Commun. 2018;2(1):48–57.

    PubMed 
    Article 
    CAS 

    Google Scholar
     

  • Fukuda T, Hamaguchi M, Kojima T, Hashimoto Y, Ohbora A, Kato T, Nakamura N, Fukui M. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals. LIVER INT. 2016;36(2):275–83.

    PubMed 
    Article 

    Google Scholar
     

  • Kim SS, Cho HJ, Kim HJ, Kang DR, Berry JR, Kim JH, Yang MJ, Lim SG, Kim S, Cheong JY, et al. Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. Dig Liver Dis. 2018;50(4):370–7.

    PubMed 
    Article 

    Google Scholar
     

  • Yoshitaka H, Hamaguchi M, Kojima T, Fukuda T, Ohbora A, Fukui M. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: a post hoc analysis of a cohort study. Medicine. 2017;96(18): e6712.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013;5(5):1544–60.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Imajo K, Hyogo H, Yoneda M, Honda Y, Kessoku T, Tomeno W, Ogawa Y, Taguri M, Mawatari H, Nozaki Y, et al. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study. PLoS ONE. 2014;9(12): e115403.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • Sun DQ, Wu SJ, Liu WY, Wang LR, Chen YR, Zhang DC, Braddock M, Shi KQ, Song D, Zheng MH. Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study. BMJ Open. 2016;6(12): e13781.


    Google Scholar
     

  • Sun DQ, Liu WY, Wu SJ, Zhu GQ, Braddock M, Zhang DC, Shi KQ, Song D, Zheng MH. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease. Oncotarget. 2016;7(5):5728–37.

    PubMed 
    Article 

    Google Scholar
     

  • Li JJ, Huang YH, Lin YY, Li MM, Chen YF, Cai RW. The association of uric acid with leukoaraiosis. J Int Med Res. 2017;45(1):75–81.

    PubMed 
    Article 
    CAS 

    Google Scholar
     

  • Xu X, Li C, Zhou P, Jiang T. Uric acid transporters hiding in the intestine. Pharm Biol. 2016;54(12):3151–5.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15(1):123.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • Darmawan G, Hamijoyo L, Hasan I. Association between serum uric acid and non-alcoholic fatty liver disease: a meta-analysis. Acta Med Indones. 2017;49(2):136–47.

    PubMed 

    Google Scholar
     

  • Al-Daghri NM, Al-Attas OS, Wani K, Sabico S, Alokail MS. Serum uric acid to creatinine ratio and risk of metabolic syndrome in Saudi type 2 diabetic patients. Sci Rep. 2017;7(1):12104.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • Gu L, Huang L, Wu H, Lou Q, Bian R. Serum uric acid to creatinine ratio: a predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function. Diab Vasc Dis Res. 2017;14(3):221–5.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Durmus KN, Sasak G, Aka AU, Akgun M, Boga S, Sengul A, Gungor S, Arinc S. Serum uric acid levels and uric acid/creatinine ratios in stable chronic obstructive pulmonary disease (COPD) patients: are these parameters efficient predictors of patients at risk for exacerbation and/or severity of disease? Med Sci Monit. 2016;22:4169–76.

    Article 

    Google Scholar
     

  • Seo YB, Han AL. Association of the serum uric acid-to-creatinine ratio with nonalcoholic fatty liver disease diagnosed by computed tomography. Metab Syndr Relat Disord. 2021;19(2):70–5.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Ma C, Liu Y, He S, Zeng J, Li P, Ma C, Ping F, Zhang H, Xu L, Li W, et al. C-Peptide: a mediator of the association between serum uric acid to creatinine ratio and non-alcoholic fatty liver disease in a chinese population with normal serum uric acid levels. Front Endocrinol. 2020;11:600472.

    Article 

    Google Scholar
     

  • Zhang N, Hu X, Zhang Q, Bai P, Cai M, Zeng TS, Zhang JY, Tian SH, Min J, Huang HT, et al. Non-high-density lipoprotein cholesterol: high-density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: Results from a population-based cohort study. J Diabetes. 2018;10(9):708–14.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Steventon JJ, Trueman RC, Ma D, Yhnell E, Bayram-Weston Z, Modat M, Cardoso J, Ourselin S, Lythgoe M, Stewart A, et al. Longitudinal in vivo MRI in a Huntington’s disease mouse model: Global atrophy in the absence of white matter microstructural damage. Sci Rep. 2016;6:32423.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Zeng MD, Li YM, Chen CW, Lu LG, Fan JG, Wang BY, Mao YM. Guidelines for the diagnosis and treatment of alcoholic liver disease. J Dig Dis. 2008;9(2):113–6.

    PubMed 
    Article 

    Google Scholar
     

  • Wang J, Xie P, Huang JM, Qu Y, Zhang F, Wei LG, Fu P, Huang XJ. The new Asian modified CKD-EPI equation leads to more accurate GFR estimation in Chinese patients with CKD. Int Urol Nephrol. 2016;48(12):2077–81.

    PubMed 
    Article 

    Google Scholar
     

  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Shamu T, Chimbetete C, Egger M, Mudzviti T. Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: a cohort study. PLoS ONE. 2021;16(6): e253000.

    Article 
    CAS 

    Google Scholar
     

  • Ding Q, Xu L, Zhu Y, Xu B, Chen X, Duan Y, Xie Z, Shen K. Comparison of clinical features of acute lower respiratory tract infections in infants with RSV/HRV infection, and incidences of subsequent wheezing or asthma in childhood. BMC Infect Dis. 2020;20(1):387.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, de Boer IH, Siscovick DS, Shlipak MG, Sarnak MJ. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant. 2010;25(5):1560–7.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Wu SJ, Zou H, Zhu GQ, Wang LR, Zhang Q, Shi KQ, Han JB, Huang WJ, Braddock M, Chen YP, et al. Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease. Medicine. 2015;94(19): e842.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Wu SJ, Zhu GQ, Ye BZ, Kong FQ, Zheng ZX, Zou H, Shi KQ, Lin L, Braddock M, Huang WJ, et al. Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study. Medicine. 2015;94(17): e802.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Groenwold RH, White IR, Donders AR, Carpenter JR, Altman DG, Moons KG. Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis. CMAJ. 2012;184(11):1265–9.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30(4):377–99.

    PubMed 
    Article 

    Google Scholar
     

  • von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.

    Article 

    Google Scholar
     

  • Rothenbacher D, Rehm M, Iacoviello L, Costanzo S, Tunstall-Pedoe H, Belch J, Söderberg S, Hultdin J, Salomaa V, Jousilahti P, et al. Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project. BMC Med. 2020;18(1):300.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Wu L, Zhang M, Hu H, Wan Q. Elevated gamma-glutamyl transferase has a non-linear association with incident non-alcoholic fatty liver disease in the non-obese Chinese population: a secondary retrospective study. Lipids Health Dis. 2021;20(1):142.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Mullee A, Romaguera D, Pearson-Stuttard J, Viallon V, Stepien M, Freisling H, Fagherazzi G, Mancini FR, Boutron-Ruault MC, Kühn T, et al. Association between soft drink consumption and mortality in 10 European Countries. JAMA Intern Med. 2019;179(11):1479–90.

    PubMed 
    Article 

    Google Scholar
     

  • Keidel D, Anto JM, Basagaña X, Bono R, Burte E, Carsin AE, Forsberg B, Fuertes E, Galobardes B, Heinrich J et al. the role of socioeconomic status in the association of lung function and air pollution-a pooled analysis of three adult escape cohorts. Int J Environ Res Public Health 2019; 16(11).

  • Sun D, Li W, Zhang H, Li Y, Zhang Q. Inverted U-shaped relationship between body mass index and multivessel lesions in Chinese patients with myocardial infarction: a cross-sectional study. J Int Med Res. 2020;48(7):1220732372.


    Google Scholar
     

  • Vesa CM, Behl T, Nemeth S, Bratu OG, Diaconu CC, Moleriu RD, Negrut N, Zaha DC, Bustea C, Radu FI, et al. Prediction of NAFLD occurrence in prediabetes patients. Exp Ther Med. 2020;20(6):190.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Shengir M, Krishnamurthy S, Ghali P, Deschenes M, Wong P, Chen T, Sebastiani G. Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome. World J Gastroenterol. 2020;26(44):7046–60.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Zhu F, Chen C, Zhang Y, Chen S, Huang X, Li J, Wang Y, Liu X, Deng G, Gao J. Elevated blood mercury level has a non-linear association with infertility in U.S. women: data from the NHANES 2013–2016. Reprod Toxicol. 2020;91:53–8.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Haneuse S, VanderWeele TJ, Arterburn D. Using the E-value to assess the potential effect of unmeasured confounding in observational studies. JAMA. 2019;321(6):602–3.

    PubMed 
    Article 

    Google Scholar
     

  • Zhou M, Yang N, Xing X, Chang D, Li J, Deng J, Chen Y, Hu C, Zhang R, Lu X, et al. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease. BMC Gastroenterol. 2021;21(1):43.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Xu C, Yu C, Ma H, Xu L, Miao M, Li Y. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study. AM J Gastroenterol. 2013;108(8):1299–304.

    PubMed 
    Article 

    Google Scholar
     

  • Wang J, Zhang Y, Liu Z, Yang Y, Zhong Y, Ning X, Zhang Y, Zhao T, Xia L, Geng F, et al. Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms. BMC Psychiatry. 2020;20(1):410.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Ge P, Yang H, Lu J, Liao W, Du S, Xu Y, Xu H, Zhao H, Lu X, Sang X, et al. Albumin binding function: the potential earliest indicator for liver function damage. Gastroenterol Res Pract. 2016;2016:5120760.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Tian J, Zhong R, Liu C, Tang Y, Gong J, Chang J, Lou J, Ke J, Li J, Zhang Y, et al. Association between bilirubin and risk of non-alcoholic fatty liver disease based on a prospective cohort study. Sci Rep. 2016;6:31006.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Akhavan RA, Dadgar MM, Ghasemi NM, Shirazinia M, Ghodsi H, Rouhbakhsh ZM, Tavakolizadeh NM, Hoseini B, Akhavan RK. Association between smoking and non-alcoholic fatty liver disease: a systematic review and meta-analysis. SAGE Open Med. 2018;6:2104817223.


    Google Scholar
     

  • Noureddin M, Loomba R. Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers. Clin Liver Dis. 2012;1(4):104–7.

    Article 

    Google Scholar
     

  • Amor AJ, Perea V. Dyslipidemia in nonalcoholic fatty liver disease. Curr Opin Endocrinol Diabetes Obes. 2019;26(2):103–8.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Shih MH, Lazo M, Liu SH, Bonekamp S, Hernaez R, Clark JM. Association between serum uric acid and nonalcoholic fatty liver disease in the US population. J Formos Med Assoc. 2015;114(4):314–20.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, Zhang Z, Yang Z. Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab. 2015;100(11):4198–207.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Lin KM, Lu CL, Hung KC, Wu PC, Pan CF, Wu CJ, Syu RS, Chen JS, Hsiao PJ, Lu KC. The paradoxical role of uric acid in osteoporosis. Nutrients. 2019;11(9):2111.

    CAS 
    PubMed Central 
    Article 

    Google Scholar
     

  • Spahis S, Delvin E, Borys JM, Levy E. Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid Redox Signal. 2017;26(10):519–41.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Jian C, Xu Y, Ma X, Shen Y, Wang Y, Bao Y. Neck circumference is an effective supplement for nonalcoholic fatty liver disease screening in a community-based population. Int J Endocrinol. 2020;2020:7982107.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • Alsabaani AA, Mahfouz AA, Awadalla NJ, Musa MJ, Al HS. Non-alcoholic fatty liver disease among type-2 diabetes mellitus patients in Abha City, South Western Saudi Arabia. Int J Environ Res Public Health. 2018;15(11):2521.

    CAS 
    PubMed Central 
    Article 

    Google Scholar
     

  • Hu X, Huang Y, Bao Z, Wang Y, Shi D, Liu F, Gao Z, Yu X. Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol. 2012;12:123.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Leite NC, Villela-Nogueira CA, Cardoso CR, Salles GF. Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment. World J Gastroenterol. 2014;20(26):8377–92.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     



  • Source link

    EHS
    Back to top button